Choose your language to see content specific to you

Zuellig Pharma joins pharmaledger association to build a digital trust ecosystem

25 Sep 2023

Share This Article

Representing the diversity of healthcare, PLA’s founding members comprise large and small pharmaceutical companies, research organisations, patient representative organisations, non-profit organisations, technology, and healthcare service providers – all coming together to solve problems that single organisations can’t solve.

Together with PLA, Zuellig Pharma will actively contribute to building the DTE-H with the goal of accelerating innovation and adoption of digital healthcare solutions in a patient-centric and industry-enabling way. Through these innovative patient-first healthcare solutions, we hope to break the silos across healthcare and achieve real-world results, while complying with healthcare regulations.

Zuellig Pharma first joined the PharmaLedger consortium in September 2021 to work towards interoperability and setting up of a multi-cloud infrastructure with all participants. Given Zuellig Pharma’s success launching eZTracker, the first production-grade pharma supply chain traceability solution powered by blockchain in Asia, they will leverage their in-house team’s blockchain expertise to contribute to key business cases of PLA like track and trace, sales rechanneling, e-product information (e-labelling) and cold chain monitoring. Zuellig Pharma is excited to define the future of healthcare with PLA through next-gen secure digital solutions and DTE-H.
Read more about PLA’s 3-year strategic plan to implement DTE-H here.

To make healthcare more accessible, Zuellig Pharma has become a Patron Member of PharmaLedger Association™ (PLA), a global not-for-profit based in Switzerland, with the vision to connect, protect, empower, build and sustain Healthcare 4.0 by enabling a Digital Trust Ecosystem in Healthcare (DTE-H).
http://eztracker.digiknowlogy.com/wp-content/uploads/2023/09/pexels-pixabay-208512-scaled.jpg
This is a caption for this image. Describe the image.
About PharmaLedger Association (PLA)

PLA was formed as a result of the successful completion of the PharmaLedger research project, a €22 million, 30-member consortium with 12 large pharma companies and 18 public partners, funded under the European Union (EU) and European Federation of Pharmaceutical Industries and Associations (EFPIA)’s Innovative Health Initiative.

Choose your language to see content specific to you